Title |
Size of Sentinel Node Tumor Deposits and Extent of Axillary Lymph Node Involvement: Which Breast Cancer Patients May Benefit From Less Aggressive Axillary Dissections?
|
---|---|
Published in |
Annals of Surgical Oncology, June 2007
|
DOI | 10.1245/s10434-007-9458-9 |
Pubmed ID | |
Authors |
Elena Samoilova, Joseph T. Davis, Jeffrey Hinson, Yolanda M. Brill, Michael L. Cibull, Patrick McGrath, Edward Romond, Angela Moore, Luis M. Samayoa |
Abstract |
In most breast cancer series, nearly 30% to 40% of all patients are sentinel node positive; however, in a large proportion of these, the disease is limited to three or fewer positive nodes. On the basis of these observations, the object of this study is to identify a subset of patients who might benefit from a less aggressive axillary dissection, without compromising staging or local disease control. We reviewed known clinicopathologic variables associated with a higher risk for axillary metastasis in 467 patients who underwent sentinel node mapping at our institution. We then compared the incidence of these variables in patients with N1a versus N2-3 stage disease. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 5% |
Denmark | 1 | 5% |
Unknown | 20 | 91% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 3 | 14% |
Professor > Associate Professor | 3 | 14% |
Student > Doctoral Student | 3 | 14% |
Student > Bachelor | 3 | 14% |
Professor | 2 | 9% |
Other | 7 | 32% |
Unknown | 1 | 5% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 77% |
Nursing and Health Professions | 1 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Economics, Econometrics and Finance | 1 | 5% |
Neuroscience | 1 | 5% |
Other | 0 | 0% |
Unknown | 1 | 5% |